Inari Medical, Inc. (NARI) Misses Q1 EPS by 26c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq futures sink as Amazon, Intel intensify AI spending fears
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts NARI Hot Sheet
Join SI Premium – FREE
Inari Medical, Inc. (NASDAQ: NARI) reported Q1 EPS of ($0.42), $0.26 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $143.2 million versus the consensus estimate of $137.8 million.
GUIDANCE:
Inari Medical, Inc. sees FY2024 revenue of $592.5-602.5 million, versus the consensus of $587.9 million.
For earnings history and earnings-related data on Inari Medical, Inc. (NARI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regal-Beloit (RBC) Tops Q3 EPS by 21c ; Offers Guidance
- Dominion Energy (D) Tops Q3 EPS by 9c, Beats on Revenue; Offers FY26 EPS Guidance
- Global chip stocks slide after Intel’s weak outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
